Xinyan Xue

772 total citations
28 papers, 548 citations indexed

About

Xinyan Xue is a scholar working on Epidemiology, Molecular Biology and Plant Science. According to data from OpenAlex, Xinyan Xue has authored 28 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Molecular Biology and 8 papers in Plant Science. Recurrent topics in Xinyan Xue's work include Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (7 papers) and Phytochemistry and biological activity of medicinal plants (5 papers). Xinyan Xue is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (7 papers) and Phytochemistry and biological activity of medicinal plants (5 papers). Xinyan Xue collaborates with scholars based in China and Thailand. Xinyan Xue's co-authors include Yunxia Li, Cheng Peng, Xingtao Zhao, Li Liao, Mengting Zhou, Yunxia Li, Ying Deng, Lihong Gong, Jing Wang and Shu Dai and has published in prestigious journals such as Journal of Ethnopharmacology, European Journal of Pharmacology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Xinyan Xue

28 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyan Xue China 15 193 124 108 103 72 28 548
Pin‐Ho Pan Taiwan 12 171 0.9× 117 0.9× 69 0.6× 116 1.1× 56 0.8× 15 480
Quan Jin China 19 366 1.9× 159 1.3× 64 0.6× 106 1.0× 73 1.0× 33 694
Yong‐Zhan Zhen China 14 212 1.1× 91 0.7× 78 0.7× 63 0.6× 52 0.7× 31 482
Mengjuan Wei China 12 227 1.2× 146 1.2× 53 0.5× 147 1.4× 70 1.0× 25 522
Xianyong Bai China 13 290 1.5× 95 0.8× 157 1.5× 116 1.1× 37 0.5× 20 641
Naihua Hu China 9 181 0.9× 141 1.1× 78 0.7× 98 1.0× 52 0.7× 11 425
Chengmu Hu China 18 387 2.0× 201 1.6× 123 1.1× 117 1.1× 44 0.6× 33 848
Shu-Ju Wu Taiwan 10 199 1.0× 115 0.9× 46 0.4× 121 1.2× 55 0.8× 10 438
Jianzhi Wu China 15 195 1.0× 200 1.6× 35 0.3× 90 0.9× 85 1.2× 25 483
Kezhen Shen China 14 195 1.0× 162 1.3× 65 0.6× 58 0.6× 82 1.1× 18 777

Countries citing papers authored by Xinyan Xue

Since Specialization
Citations

This map shows the geographic impact of Xinyan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyan Xue more than expected).

Fields of papers citing papers by Xinyan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyan Xue. The network helps show where Xinyan Xue may publish in the future.

Co-authorship network of co-authors of Xinyan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyan Xue. A scholar is included among the top collaborators of Xinyan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyan Xue. Xinyan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Xinyan, Yanzhi Li, Yuxin Yao, et al.. (2024). Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis. Phytomedicine. 132. 155830–155830. 4 indexed citations
2.
Xue, Xinyan, Yanzhi Li, Yanzhi Li, et al.. (2024). A comprehensive review of miR-21 in liver disease: Big impact of little things. International Immunopharmacology. 134. 112116–112116. 6 indexed citations
3.
Xue, Xinyan, Jing Wang, Ke Fu, et al.. (2023). The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis. International Immunopharmacology. 116. 109775–109775. 12 indexed citations
4.
Zhao, Xingtao, Felix Kwame Amevor, Xinyan Xue, et al.. (2023). Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review. Journal of Nanobiotechnology. 21(1). 121–121. 23 indexed citations
5.
Fu, Ke, Shu Dai, Yanzhi Li, et al.. (2023). The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(8). 166822–166822. 5 indexed citations
6.
Wang, Cheng, Yanfang Liu, Lihong Gong, et al.. (2023). Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway. Inflammation. 46(4). 1543–1560. 14 indexed citations
7.
Zhao, Xingtao, Felix Kwame Amevor, Zhifu Cui, et al.. (2023). Steatosis in metabolic diseases: A focus on lipolysis and lipophagy. Biomedicine & Pharmacotherapy. 160. 114311–114311. 15 indexed citations
8.
Wang, Jing, Xinyan Xue, Xingtao Zhao, et al.. (2023). Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex. Journal of Advanced Research. 60. 183–200. 49 indexed citations
9.
Zhang, Fang, Rui Wu, Yanfang Liu, et al.. (2023). Nephroprotective and nephrotoxic effects of Rhubarb and their molecular mechanisms. Biomedicine & Pharmacotherapy. 160. 114297–114297. 27 indexed citations
10.
Wu, Rui, Fang Zhang, Shu Dai, et al.. (2023). Protective mechanism of Paeonol on central nervous system. Phytotherapy Research. 38(2). 470–488. 15 indexed citations
11.
Zhou, Mengting, Xingtao Zhao, Li Liao, et al.. (2022). Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4‐Dependent ROS. Oxidative Medicine and Cellular Longevity. 2022(1). 9938392–9938392. 25 indexed citations
12.
Wang, Jing, Lin Luo, Xingtao Zhao, et al.. (2022). Forsythiae Fructuse extracts alleviates LPS-induced acute lung injury in mice by regulating PPAR-γ/RXR-α in lungs and colons. Journal of Ethnopharmacology. 293. 115322–115322. 22 indexed citations
13.
Zhao, Xingtao, Xinyan Xue, Cheng Wang, et al.. (2022). Emerging roles of Sirtuins in alleviating alcoholic liver Disease: A comprehensive review. International Immunopharmacology. 108. 108712–108712. 20 indexed citations
14.
Liao, Li, et al.. (2021). Leonurine Ameliorates Oxidative Stress and Insufficient Angiogenesis by Regulating the PI3K/Akt‐eNOS Signaling Pathway in H2O2‐Induced HUVECs. Oxidative Medicine and Cellular Longevity. 2021(1). 9919466–9919466. 31 indexed citations
15.
Gong, Lihong, Li Liao, Xuyang Dai, et al.. (2021). The dual role of immune response in acetaminophen hepatotoxicity: Implication for immune pharmacological targets. Toxicology Letters. 351. 37–52. 10 indexed citations
16.
Liao, Li, Mengting Zhou, Jing Wang, et al.. (2021). Identification of the Antithrombotic Mechanism of Leonurine in Adrenalin Hydrochloride-Induced Thrombosis in Zebrafish via Regulating Oxidative Stress and Coagulation Cascade. Frontiers in Pharmacology. 12. 742954–742954. 12 indexed citations
17.
18.
Xue, Xinyan, Ying Deng, Jing Wang, et al.. (2021). Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis. Phytomedicine. 91. 153694–153694. 69 indexed citations
19.
Xue, Xinyan, Yunyun Quan, Lihong Gong, Xiaohong Gong, & Yunxia Li. (2020). A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicology. Journal of Ethnopharmacology. 261. 113121–113121. 33 indexed citations
20.
Hu, Naihua, Jie Liu, Xinyan Xue, & Yunxia Li. (2020). The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. European Journal of Pharmacology. 882. 173269–173269. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pin‐Ho Pan Breakdown of academic impact, for papers by Quan Jin Breakdown of academic impact, for papers by Yong‐Zhan Zhen Breakdown of academic impact, for papers by Mengjuan Wei Breakdown of academic impact, for papers by Xianyong Bai Breakdown of academic impact, for papers by Naihua Hu Breakdown of academic impact, for papers by Chengmu Hu Breakdown of academic impact, for papers by Shu-Ju Wu Breakdown of academic impact, for papers by Jianzhi Wu Breakdown of academic impact, for papers by Kezhen Shen
Rankless by CCL
2026